Ambrx Biopharma Inc. Cash Flow Breakdown
Cash flow breakdown shows where Ambrx Biopharma Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.
- Fiscal year ended 2022-12-31: from running the business, $68.67M went out.
- Fiscal year ended 2022-12-31: from investing, $46.72M went out.
- Fiscal year ended 2022-12-31: from financing, $928.00K came in.
- Fiscal year ended 2022-12-31: change in cash, $114.47M went out.
A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.
Each year (12 month)
| Fiscal year end | Running the business | From investing | New shares sold | Not split out | Change in cash |
|---|---|---|---|---|---|
| 2022-12-31 | -$68.67M | -$46.72M | $138.00K | $790.00K* | -$114.47M |
| 2021-12-31 | -$44.64M | -$3.21M | $148.73M | -$21.30M* | $79.63M |
| 2020-12-31 | -$20.58M | -$252.00K | $0.00 | $95.68M* | $75.02M |
| 2019-12-31 | -$2.77M | -$48.00K | $0.00 | -$2.85M |
Each quarter (3 month)
| Quarter end | Running the business | From investing | New shares sold | Not split out | Change in cash |
|---|---|---|---|---|---|
| 2023-06-30 | -$13.15M* | $9.18M* | $82.65M* | ||
| 2023-03-31 | -$12.97M | $29.55M | $77.78M | -$559.00K* | $93.81M |
| 2022-06-30 | -$14.53M* | -$63.43M* | $95.00K* | ||
| 2022-03-31 | -$25.66M | -$774.00K | $7.00K | -$26.44M |